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Abstract
Summary Determinants of trabecular bone score (TBS) and vertebral fractures assessed semiquantitatively (SQ1–SQ3) were
studied in 496 women with fragility fractures. TBS was associated with age, parental hip fracture, alcohol intake and BMD, not
SQ1–SQ3 fractures. SQ1–SQ3 fractures were associated with age, prior fractures, and lumbar spine BMD, but not TBS.
Introduction Trabecular bone score (TBS) and vertebral fractures assessed by semiquantitative method (SQ1–SQ3) seem to
reflect different aspects of bone strength. We therefore sought to explore the determinants of and the associations between TBS
and SQ1–SQ3 fractures.
Methods This cross-sectional sub-study of the Norwegian Capture the Fracture Initiative included 496 women aged ≥ 50 years
with fragility fractures. All responded to a questionnaire about risk factors for fracture, had bone mineral density (BMD) of
femoral neck and/or lumbar spine assessed, TBS calculated, and 423 had SQ1–SQ3 fracture assessed.
Results Mean (SD) age was 65.6 years (8.6), mean TBS 1.27 (0.10), and 33.3% exhibited SQ1–SQ3 fractures. In multiple
variable analysis, higher age (βper SD = − 0.26, 95% CI: − 0.36,− 0.15), parental hip fracture (β = − 0.29, 95% CI: − 0.54,− 0.05),
and daily alcohol intake (β = − 0.43, 95%CI − 0.79, − 0.08) were associated with lower TBS. Higher BMD of femoral neck (βper
SD = 0.34, 95% CI 0.25–0.43) and lumbar spine (βper SD = 0.40, 95% CI 0.31–0.48) were associated with higher TBS. In
multivariable logistic regression analyses, age (ORper SD = 1.94, 95% CI 1.51–2.46) and prior fragility fractures (OR = 1.71, 95%
CI 1.09–2.71) were positively associated with SQ1–SQ3 fractures, while lumbar spine BMD (ORper SD = 0.75 95% CI 0.60–
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0.95) was negatively associated with SQ1–SQ3 fractures. No association between TBS and SQ1–SQ3 fractures was found.
Conclusion Since TBS and SQ1–SQ3 fractures were not associated, theymay act as independent risk factors, justifying the use of
both in post-fracture risk assessment.
Keywords Bonemineral density . Fracture risk . Osteoporosis . Trabecular bone score . Vertebral fracture assessment . Vertebral
fractures
Introduction
In recent years, trabecular bone score (TBS) and vertebral
fracture assessment (VFA) have become established methods
in clinical use, providing supplemental information on bone
strength and future fracture risk [1–3]. Identification of the
determinants of these indices is important for further under-
standing the pathophysiology of fracture risk and for identifi-
cation of modifiable factors to prevent future fractures.
TBS is a grey-level textural index of trabecular bone
microarchitecture obtained from dual-energy absorptiom-
etry (DXA) images of the lumbar spine [4]. It is, however,
still subject to discussion, which bone properties TBS
actually reflects [5]. TBS predicts fragility fractures inde-
pendently of bone mineral density (BMD) [2, 6–8]. The
use of TBS for adjustment of 10-year probability of a hip
or other major osteoporotic fracture (MOF) calculated by
the Fracture Risk Assessment Tool (FRAX) is endorsed
[9]. The retrospective Manitoba study is the largest study
on determinants of TBS (n = 29,407 women)[10]. They
found that TBS was negatively associated with glucocor-
ticoid use, prior major fracture, rheumatoid arthritis,
chronic obstructive pulmonary disease, high alcohol in-
take and higher body mass index (BMI) and positively
associated with femoral neck and lumbar spine BMD,
and 7–11% of the variation in TBS was explained by
BMD [10]. Genetic factors explained approximately
45% of the variance in TBS in healthy Vietnamese sub-
jects, whereas sex, age, and height accounted for about
28% of the total variance in TBS [11].
The presence of a vertebral fracture doubles the risk of
subsequent fracture at any given BMD [12]. VFA of lat-
eral spine x-rays is therefore recommended as a part of the
post-fracture risk assessment [13]. With higher resolution
and image quality of modern DXA equipment, VFA of
spine images obtained by DXA has become easily avail-
able and provides reliable information on vertebral frac-
ture status in the thoracolumbar spine (T4–L4) at a much
lower radiation dose compared to conventional lateral
spine x-rays. Determinants as age, BMD, height loss,
and prior non-vertebral fractures are associated with prev-
alent vertebral fractures in a large population-based cohort
study [14]. In the Rotterdam Study, incident vertebral
fractures were reported to be strongly associated with
prevalent vertebral fractures, early menopause, current
smoking, use of walking aids, and low BMD [15]. In
addition, the population-based European Prospective
Osteoporosis Study (EPOS) showed that low BMD, low
BMI, and late menarche were associated with higher inci-
dence of vertebral fractures while use of hormonal re-
placement therapy (HRT) was protective [16]. No associ-
ations between lifestyle factors such as smoking, alcohol
intake, physical activity, or milk consumption and inci-
dent vertebral fracture were found in that study. A herita-
bility of vertebral fractures (vertebral height reduction >
25%) of more than 43% has been demonstrated [17].
Studies on the association between TBS and vertebral
fractures diverge. Low TBS has been shown to be asso-
ciated with a higher prevalence of vertebral fractures on
VFA in women [18, 19], but there are also studies contra-
dicting this notion [20]. In the prospective Manitoba
study, TBS was associated with incident vertebral frac-
tures in women but not in men [21]. Moreover, TBS
was not associated with incident vertebral fractures in
the men in the MrOs study [22]. In a previous publication
of results from this sub-study of Norwegian Capture the
Fracture Initiative (NoFRACT), we reported that more
than half of the patients who had sustained a fragility
fracture exhibited low TBS (≤ 1.23), prevalent fracture
on VFA or both [23]. Only 14% of these patients exhib-
ited osteoporosis at the femoral neck, which increased to
28% when using the site with lowest BMD T-score. In the
patients with osteopenia at the femoral neck, 34% exhib-
ited low TBS, 33% vertebral fracture on VFA, but only
13% exhibited both low TBS and prevalent vertebral frac-
ture. This is suggesting that TBS and VFA captured dif-
ferent aspects of bone strength. To better understand the
potential pathophysiology underlying this diversity, iden-
tification of the determinants of both traits in the same
cohort is of interest. Keeping in mind that heritability is
a major determinant, investigation of clinical phenotypes
and modifiable environmental risk factors may enable
identification and treatment of individuals at risk. To our
knowledge, this has not been studied in individuals with
fractures. The objectives of this study were therefore (i) to
explore the determinants of TBS and prevalent vertebral
fractures on VFA, (ii) to explore whether prevalent verte-
bral fractures are determinants of TBS, and (iii) to explore
whether TBS is a determinant of vertebral fractures in a




NoFRACT is a multicenter study at seven hospitals in Norway
with 34,976 persons with fragility fractures enrolled by
Jan 2019 [24]. The main aim is to investigate the effect of
introducing a standardized intervention program consisting
of a Fracture Liaison Service model of care for identification,
assessment, and treatment of osteoporosis in patients with
fragility fractures on the rate of subsequent fractures. Both
women and men aged 50 years and older, who have recently
sustained a clinical fragility fracture, are eligible to the inter-
vention, with the exception of patients with fracture in fingers,
toes, skull, and face.
This cross-sectional sub-study (NCT02608801) of
NoFRACT (NCT02536898) included patients at the
University Hospital of North Norway, Tromsø, from 1
Oct 2015 to 31 Dec 2017 and at Drammen Hospital in
the south-eastern part of Norway from 1 Jan 2016 to 31
Dec 2017 [23, 25]. Of all patients of 50 years of age and
above, attending to these hospitals with a fragility frac-
ture, more than 90% (n = 2682) were identified and of-
fered fracture risk assessment. For elderly in-patients with
fractures of hip, vertebrae, a total of two or more fragility
fractures, or 10-year probability of MOF ≥ 20% calculated
using FRAX, the treatment decision was made without the
need of DXA scan (n = 1235). The participants were
recruited among those who were referred to DXA (n =
1447), of whom 839 consented to participate in the study,
675 women and 164 men [23]. We included a total of 496
women who all had responded to a questionnaire on risk
factors for fracture, had valid measurement of TBS, and
BMD of the femoral neck and lumbar spine, and 423 of
them had VFA performed. No patients were excluded due
to conditions known to affect bone metabolism, such as
chronic kidney disease, use of anti-osteoporosis drugs,
HRT, or premenopausal status. The study was approved
by The Regional Committee for Medical and Health
Research Ethics (REK 2014/2260).
Variables
The index fractures leading to inclusion were fragility frac-
tures of the forearm (n = 196), ankle (n = 90), proximal hu-
merus (n = 68), hip (n = 36), vertebrae (thoracic and lumbar)
(n = 23), and other sites (n = 83). No women had rib or
cervical fractures as index fracture. The vertebral fractures that
led to inclusion were diagnosed on x-ray, CT, or MRI, not by
VFA. Information on number of fractures after the age of 50,
number of falls during the last 12 months before inclusion,
parental history of hip fractures (yes vs. no), comorbidity,
medication, postmenopausal status (yes vs. no), age at
menopause, number of children, total months of
breastfeeding, smoking (yes vs. no), daily alcohol intake
(yes vs. no), physical activity (h/week), and dairy products
(units/day) were collected through a questionnaire.
Height and weight was measured without shoes and heavy
clothing, and BMI was calculated as weight per square meter
height. BMD was measured at the lumbar spine (L1–L4), fem-
oral neck, and total hip at both sides and using DXA Prodigy
Pro in Tromsø and iDXA Pro in Drammen (both GE Lunar,
Madison, WI, USA). Phantom Quality Assurance (QA) of the
DXA equipment was performed daily. All fractured lumbar
vertebrae were excluded, and BMD T-scores at femoral neck
and total hip were calculated using the Third National Health
and Nutrition Examination Survey with reference data of fe-
male Caucasians aged 20–29 years [26]. iNsight software
(MediMaps, Geneva, Switzerland) version 3.0.1 was used to
calculate TBS values from the DXA scans used for lumbar
spine BMD (L1–L4), and fractured vertebrae were excluded.
European (Medimaps) reference population was used.
Lateral images of the thoracolumbar spine (T4–L4) were
obtained from DXA scans with the patient in a lateral
decubitus position with lumbar support and hips flexed 90
degrees. An experienced physician (TTB) performed VFA
and grading of the fracture severity using Genant’s method
for the semiquantitative (SQ) vertebral fracture scoring [27].
This combines the visual identification of fracture of vertebral
bodies (height loss of the anterior, middle, posterior, or the
whole vertebra) and grading of the fracture by percentage of
height loss. A SQ score of 0 (SQ0) (< 20% height loss) is a
non-fractured vertebra, SQ1 (20–25% height loss) a mild frac-
ture, SQ2 (25–40% height loss) a moderate fracture, and SQ3
(≥ 40% height loss) a severe fracture. We classified the pres-
ence of one or more SQ1, SQ2, or SQ3 fractures as SQ1–SQ3
fractures, one or more SQ2 or SQ3 fractures as SQ2–SQ3
fractures, and presence of at least one SQ3 fracture as ≥
SQ3. The inter-observer agreement of SQ1–SQ3 fractures
tested against another experienced clinician showed a κ of
0.84 (95% CI 0.70, 0.98) [23].
Statistical analyses
Characteristics of the cohort were calculated as mean ± stan-
dard deviation (SD) for the continuous variables and number
with percentages (%) for categorical variables. Continuous
variables were checked for normality using quantile-quantile
(QQ) plot. All these variables were normally distributed ex-
cept breastfeeding which was log-transformed in further anal-
yses. Scatterplots were performed between continuous vari-
ables and visually checked for linearity. Univariable linear
regression analyses were performed to investigate associa-
tions between the outcome variable TBS and clinical relevant
determinants (age, BMI, history of prior fractures after the age
of 50, falls during the last 12months before inclusion, parental
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history of hip fractures, comorbidities, use of medications,
number of children, breastfeeding, currently smoking, daily
alcohol consumption, physical activity, consumption of dairy
products, prevalence of SQ1–SQ3 fractures, femoral neck and
lumbar spine BMD). Only determinants significant at p-level
< 0.10 were retained and included in multivariable models.
Multiple linear regression analyses were performed, and be-
cause of potential multi-collinearity between TBS, femoral
neck, and lumbar spine BMD, we tested different models for
each of the traits to explore the attributional variance in the
outcome variable by the introduced determinants. Non-
significant determinants were removed one by one until the
exposure variables with statistical significant association
remained (p < 0.05). Determinants that had been removed
were reintroduced one by one to re-check for significance.
Results are presented as β coefficients with 95% confidence
intervals (CIs), p values, and explained variance (R2). The
same procedure was performed with femoral neck and lumbar
spine BMD as outcome variables. Univariable logistic regres-
sion analyses were performed to explore associations between
SQ1–SQ3 fractures (yes vs. no) as the outcome variable and
the determinants used in the linear regression models (listed
above). Variables with significant association at p level < 0.10
were included in the multivariable logistic regression analy-
ses. We tested different models including TBS, femoral neck,
and lumbar spine BMD as determinants to evaluate the
association with SQ1–SQ3 fractures. Determinants without
significant association with the outcome SQ1–SQ3 frac-
tures were removed one by one until the final model
contained only the exposure variables with significant as-
sociation (p < 0.05). Then, the removed variables were
reintroduced one by one to re-check for significance.
Results are presented by odds ratio (OR) with 95% CI.
Evaluation of the predictive accuracy of the models was
assessed by calibration and discrimination. Calibration was
evaluated by the Hosmer and Lemeshow goodness-of-fit
tes t . A stat is t ical ly non-signif icant Hosmer and
Lemeshow result (p > 0.05) suggests that the fit of the
model is acceptable. Discrimination of SQ1–SQ3 fractures
was evaluated by analysis of the area under the receiver
operating characteristic (ROC) curve. We defined accept-
able discriminatory capability as an area under the ROC
curve greater than 0.7. Standardized regression coefficients
(βper SD) or odds ratio (ORper SD) with 95% CI was used to
facilitate the comparison of the strength of the associations
between the continuous exposure variables and the out-
come variables. The number of determinants in the multi-
ple linear regression models did not exceed 10% of the
number of observations. The number of determinants in
the multiple logistic regression models never exceeded
14, as there were 141 SQ1–SQ3 fractures (maximum 10
events per determinant). All analyses were performed
using Stata v15 (Version 15, StataCorp LP, TX, USA).
Results
The mean age of the 496 women was 65.6 years (± 8.6) and
193 (42.1%) women had sustained one or more fractures prior
to the index fracture after the age of 50 (Table 1). One in three
exhibited SQ1–SQ3 fractures on VFA. Mean TBS was 1.27
and BMD at femoral neck, total hip, and lumbar spine was
0.795 g/cm2, 0.835 g/cm2, and 1.027 g/cm2, respectively. The
mean number of falls during the last 12 months prior to
Table 1 Characteristics of 496 women 50 years and older with a recent
fragility fracture
Number Total
Age, years 496 65.6 ± 8.6
Body mass index, kg/m2 496 26.1 ± 4.0
History of prior fracture after age of 50 459 193 (42.1)
Number of falls during the last 12 months 489 1.3 ± 0.7
Parental history of hip fracture 410 100 (24.4)
Ulcus/gastritis 476 56 (11.8)
Asthma/COLD 489 53 (10.8)
Type 1 and type 2 diabetes 495 23 (4.6)
Rheumatoid arthritis 488 22 (4.5)
Myocardial infaction 496 13 (2.6)
Cancer 495 71 (14.3)
Hypothyreosis 490 54 (11.2)
Hyperthyreosis 490 13 (2.7)
Use of antacids 483 76 (15.7)
Use of statins 488 119 (24.4)
Use of oral glucocorticoids 486 28 (5.8)
Menopausal estrogen supplementation 436 29 (6.7)
Use of AOD at baseline 446 41 (9.2)
Postmenopausal status 447 429 (96.0)
Age at menopause, years 399 48.7 ± 4.9
Number of children 432 2.2 ± 1.2
Nullipara 432 34 (7.8)
Breastfeeding, monthsa 325 10 (0 – 96)
No breastfeeding 325 45 (13.9)
Currently smoking 479 71 (14.8)
Daily alcohol intake 487 48 (9.8)
Physical activity, h/week 454 2.8 ± 1.8
Intake of dairy products, units/day 480 2.3 ± 1.1
Trabecular bone score lumbar spine 496 1.27 ± 0.10
SQ1-SQ3 fracture 423 141 (33.3)
Femoral neck BMD, g/cm2 482 0.795 ± 0.105
Total hip BMD, g/cm2 482 0.835 ± 0.118
Lumbar spine BMD, g/cm2 496 1.027 ± 0.166
Lowest BMD any site, T-score 496 − 2.1 ± 0.9
COLD chronic obstructive lung disease, AOD anti-osteoporosis drugs,
SQ vertebral fractures assessed by semiquantitative method, BMD bone
mineral density
Values are mean ± SD or n (%), except amedian (range)
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inclusion was 1.3, about one in four women reported a history
of parental hip fracture, and one in ten reported daily alcohol
intake. The women had on average given birth to 2.2 children
(including the 7.8% of the women who were nulliparous). The
median duration of total time of breastfeeding was 10 months
(range 0–96 months).
Determinants of TBS
Higher age (βper SD = − 0.26, 95%CI − 0.36, − 0.15), a history
of parental hip fracture (β = − 0.29, 95% CI − 0.54, − 0.05),
and daily alcohol intake (yes vs. no) (β = − 0.43, 95% CI −
0.79, − 0.08) were associated with a lower TBS (Table 2; Fig.
1). Higher age at menopause (βper SD = 0.11, 95% CI 0.01,
0.21), higher BMD of the femoral neck (βper SD = 0.34, 95%
CI 0.25, 0.43), and lumbar spine (βper SD = 0.40, 95% CI 0.31,
0.48) were associatedwith higher TBS. Inmodels additionally
including SQ1–SQ3 fractures, femoral neck or lumbar spine
BMD, age at menopause were no longer associated with TBS.
SQ1–SQ3 fractures were not associated with TBS in models
including age and daily alcohol consumption. Replacing
SQ1–SQ3 fractures with SQ2–SQ3 fractures or SQ3 fractures
in multivariable analyses did not change the results. The mod-
el including the significant determinant age, parental hip frac-
ture, daily alcohol consumption, number of children, and lum-
bar spine BMD explained 28% of the variance in TBS.
Femoral neck BMD explained 8% and lumbar spine BMD
18% of the variance in TBS.
Determinants of SQ1–SQ3 fractures
Age (ORper SD = 1.94, 95% CI 1.51–2.46) and a history of
prior fractures (OR = 1.71, 95%CI 1.09–2.71) were positively
associated with SQ1–SQ3 fractures (Table 3). Lumbar spine
BMD (ORper SD = 0.75 95% CI 0.60–0.95) was negatively
associated with SQ1–SQ3 fractures in models including age
and prior fracture. SQ1–SQ3 fractures were neither associated
with TBS nor femoral neck BMD inmodels including age and
prior fractures. In analyses with SQ2–SQ3 fractures and SQ3
fractures as outcome variables, the results were similar.
Determinants of femoral neck BMD
Higher age (βper SD = − 0.35, 95% CI: − 0.43, − 0.27) was
associated with lower femoral neck BMD, while higher BMI
(βper SD = 0.28, 95%CI: 0.20, 0.36) and higher TBS (βper SD =
0.32, 95% CI: 0.25, 0.40) were associated with higher femoral
neck BMD (Table 4). Age, BMI, myocardial infarction, and
TBS explained 32% of the variance in femoral neck BMD.













































































































































































































































































































































































































































































































































































































































































































































































































Determinants of lumbar spine BMD
SQ1–SQ3 fractures (βper SD = − 0.25, 95% CI − 0.43, − 0.07)
were associated with a lower lumbar spine BMD, while higher
age (βper SD = 0.20, 95%CI 0.12, 0.29), higher BMI (βper SD =
0.20, 95% CI 0.12, 0.29), diabetes (β = 0.61, 95% CI: 0.21,
1.00) and high TBS (βper SD = 0.43, 95% CI 0.34, 0.51) were
associated with higher lumbar spine BMD (Table 5). TBS and
SQ1–SQ3 fractures explained 17% and 1% of the variance in
lumbar spine BMD, respectively.
Discussion
No association between TBS and SQ1–SQ3 fractures could be
demonstrated in this cohort of women with prevalent fragility
fractures. We found that higher age, a history of parental hip
fracture, and daily alcohol consumption were associated with
lower TBS, while higher femoral neck and lumbar spine BMD
were associated with higher TBS. Age and prior fractures
were positively associated with SQ1–SQ3 fractures, whereas
lumbar spine BMDs were negatively associated with SQ1–
SQ3 fractures.
The unexpected finding of no association between TBS
and SQ1–SQ3 fractures has previously been shown in a study
of elderly Swedish women with prevalent vertebral fractures
[20] and in men in the Manitoba study and MrOs study with
incident vertebral fractures [21, 22]. There are other studies
showing an association between TBS and SQ1–SQ3 fractures
in women [18, 19]. We do not know why these findings
diverge between studies, but several factors may be of impor-
tance. Firstly, genetic factors explain a large part of the varia-
tion in TBS and vertebral fractures, and genetic factors may
vary significantly between countries and the cohorts studied.
Scandinavian women are a genetically homogenous group,
and they have the highest prevalence of vertebral fractures in
Europe [28]. Secondly, TBS is derived from the same images
as lumbar spine BMD. Lumbar spine BMD accounted for a
larger contribution to the variance of TBS (20%) than femoral
neck BMD (10%) in our cohort. SQ1–SQ3 fractures were
negatively associated with lumbar spine BMD, and only about
1% of the variance in lumbar spine BMD was explained by
SQ1–SQ3 fractures, suggesting a weak association. No asso-
ciation between SQ1–SQ3 fractures and femoral neck BMD
was found. We might infer that in our cohort of women with
fragility fractures, SQ1–SQ3 fractures reflect reduced bone
strength that is not captured by BMD nor TBS.
The determinants of TBS identified in our study differ
somewhat from what was found in the population-based
Canadian Manitoba study [10]. We found a negative associa-
tion of TBS with age and daily alcohol intake, but no associ-
ations with BMI, glucocorticoid use, rheumatoid arthritis, or
chronic obstructive pulmonary disease. This could be due to
the smaller sample size in our study compared to theManitoba
study (496 vs. 29,407) or that the source of the data differed.
We collected self-reported information on lifestyle, comorbid-
ities, and medication, with limitations regarding self-reported
data (i.e. possible information bias). In the Manitoba study,
this information was retrieved from register-based data of phy-
sician billing claims, hospital discharge abstracts, and
Fig. 1 Associations between
femoral neck and lumbar spine
bone mineral density (BMD),
trabecular bone score (TBS) and
vertebral fractures on VFA (SQ1-
SQ3) with attributed variance of














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































provincal retail pharmacy database, with uncertainities regard-
ing the validity of registered information (i.e. whether the
discharge record reflects the disease at hand). Both studies
reported a positive association between femoral neck and lum-
bar spine BMD and TBS. The variance in TBS explained by
femoral neck and lumbar spine BMD in the Manitoba women
was 7% and 11%, respectively, compared to 20% and 28% in
the NoFRACTwomen. This might be explained by the inclu-
sion of healthier subjects in the Manitoba cohort where only
14% had a previous major fracture, compared to the
NoFRACTcohort, where all the women had a clinical fragility
fracture. In addition, patients with BMI > 37 kg/m2 were not
excluded in the Manitoba study, which may have diluted the
association between BMD and TBS.
We found higher OR for SQ1–SQ3 fractures in patients
with a history of a prior fracture, increasing age and decreas-
ing lumbar spine BMD, in line with other studies [29–31]. No
association between SQ1–SQ3 fractures and body weight or
BMI was found in adjusted models, which is in accordance
with some studies [29–31], but contrary to others [32, 33].
Studies on incident vertebral fractures, however, show similar
results. In the EPOS study, including 3402 women, late men-
arche (after 16 years of age) was associated with an increased
risk of incident vertebral fracture, whereas HRT, increasing
body weight, and BMI were protective [16]. Lifestyle factors
such as smoking, alcohol intake, physical activity, or milk
consumption showed no association with incident vertebral
fractures, in line with our findings in patients with prevalent
vertebral fractures. In the prospective population-based
Rotterdam Study including 2467 women, age, low BMD,
prevalent vertebral fractures, early menopause (< 45 years of
age), currently smoking, and walking aid use were associated
with incident vertebral fractures in women [15]. Prevalent and
incident vertebral fractures are not comparable, although the
risk factors should be similar.
To the best of our knowledge, this is the first study on
determinants of TBS in a cohort of women with fragility frac-
tures. However, there are some limitations. The study sample
was perhaps too small to show associations with the main
outcome variables (TBS, SQ1–SQ3 fractures) and certain risk
factors, such as glucocorticoid use, rheumatoid arthritis, and
chronic obstructive pulmonary disease. On the other hand, we
showed that more of the variance in TBS could be explained
by BMD than in the Manitoba study, maybe due to exclusion
of obese patients or the selection of patients who all had suf-
fered at least one fragility fracture. As a result of the cross-
sectional design, it was not possible to determine the temporal
nature of any observed associations.
In conclusion, no statistical significant association between
TBS and SQ1–SQ3 fractures was found. Higher age, a history
of parental hip fracture, and daily alcohol consumption were
associated with lower TBS, while higher femoral neck and















































































































































































































































































































































































































































































































































































































































































































and a history of prior fractures were positively associated with
SQ1–SQ3 fractures, while lumbar spine BMDwas negatively
associated with SQ1–SQ3 fractures. Modifiable risk factors
such as daily alcohol intake and low BMD are important tar-
gets in fracture prevention strategies. Since TBS and SQ1–
SQ3 fractures are not associated, each of them may act as
independent risk factors for fracture, justifying the use of both
in post-fracture risk assessment.
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